News
UC Consortium Formed to Speed Up Development of New Drugs
The odds of developing a blockbuster drug are slim. Thousands of compounds are screened, and only about one in 10 drugs that survive the initial stages to enter clinical trials eventually receives approval. The road from discovery to drug product can take more than a decade and cost more than $2 billion.
How can the drug discovery process be improved?
Startup Commercializes UCLA "Lung Simulation" Technology
Bosley recently finalized the lung phantom’s first prototype, which he will take to partners at UCLA; next, he hopes to start printing lungs from actual patients’ CT scans and let oncologists test the simulator. The patent-pending technology, owned by UCF and UCLA and is licensed to SegAna, will cost in the $8,000 range, Bosley said. It can be used as a teaching tool, or for planning patients’ radiation treatment.
UCLA Launches Campus-wide 2017 Biomedical Competition
The 2017 Fund for Innovation will be the first campus-wide biomedical competition with three tracks: therapeutics, medical devices/diagnostics, and digital health. View the brochure for dates and more information.
New Report: UCLA Among Nation’s Best for Commercializing Research
CLA is No. 1 in the nation when it comes to the number of startup companies launched as a result of campus research, according to the rankings by the Milken Institute, an independent economic think tank based in Santa Monica.